Loading clinical trials...
Loading clinical trials...
Peanut Sublingual Immunotherapy Induction of Clinical Tolerance of Newly Diagnosed Peanut Allergic 12 to 48 Month Old Children
Conditions
Interventions
Liquid Peanut Extract
Placebo Glycerin SLIT
Locations
2
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Start Date
January 1, 2015
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2020
Last Updated
January 10, 2022
NCT03539692
NCT06369467
NCT00267501
NCT05695261
NCT06260956
NCT06034678
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions